Presentation is loading. Please wait.

Presentation is loading. Please wait.

133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular.

Published byClarissa Gregory Modified over 5 years ago

Similar presentations

Presentation on theme: "133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular."— Presentation transcript:

1 133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy  Molecular Therapy  Volume 20, (May 2012) DOI: /S (16) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

2 Molecular Therapy 2012 20, DOI: (10.1016/S1525-0016(16)35937-8)
Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

3 Molecular Therapy 2012 20, DOI: (10.1016/S1525-0016(16)35937-8)
Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Download ppt "133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular."

Similar presentations

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes
Volume 20, Issue 2, (February 2012)

Volume 20, Issue 2, (February 2012)
414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 
209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.
446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,
Genome-editing Technologies for Gene and Cell Therapy

Genome-editing Technologies for Gene and Cell Therapy
627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.
Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Evolving Gene Therapy in Primary Immunodeficiency

Evolving Gene Therapy in Primary Immunodeficiency
343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)

343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)
In This Issue Cell Volume 158, Issue 5, (August 2014)

In This Issue Cell Volume 158, Issue 5, (August 2014)
152. The Effects of AdVEGF-B and AdVEGF-D on Angiogenesis and Arteriogenesis in a Novel Porcine Model of Percutaneous Bottleneck Stent Induced Chronic.

152. The Effects of AdVEGF-B and AdVEGF-D on Angiogenesis and Arteriogenesis in a Novel Porcine Model of Percutaneous Bottleneck Stent Induced Chronic.
637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles    Molecular Therapy  Volume 20, (May.

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles    Molecular Therapy  Volume 20, (May.
Escaping the Valley of Death

Escaping the Valley of Death
220. AAV-Mediated miR122 Overexpression Rescues Hepatic Inflammatory Response Induced by Acute Iron-Overload  Min Li, Yuxiao Tang, Lusha Wu, Fengfeng.

220. AAV-Mediated miR122 Overexpression Rescues Hepatic Inflammatory Response Induced by Acute Iron-Overload  Min Li, Yuxiao Tang, Lusha Wu, Fengfeng.

Similar presentations

Ads by Google